Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04976933 · ClinicalTrials.gov registry record
Post-HSCT Medication Adherence mHealth App
A clinical trial of Stem Cell Transplantation, sponsored by Micah Skeens.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT04976933 is a study of Stem Cell Transplantation that has completed, run by Micah Skeens. The registered enrollment target is 15 participants, below the 43-participant average among 8 other Stem Cell Transplantation trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04976933, a study of Stem Cell Transplantation, has completed, sponsored by Micah Skeens.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Through a mixed methods, quasi-experimental design, the study will first focus on developing a mobile health (mHealth) adherence application and evaluating usability and acceptability of the app among caregivers of children in the acute phase post-HSCT. The purpose of this project is to explore the feasibility and acceptability of a mHealth application through user testing and thematic content analysis.
Conditions Studied
Interventions
- BEHAVIORAL mHealth adherence app
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2023-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04976933
The ClinicalTrials.gov registry entry for NCT04976933 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 43-participant average among 8 other Stem Cell Transplantation trials with a reported enrollment target (65% lower). The listed sponsor is Micah Skeens, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stem Cell Transplantation appearing as the primary indexed condition, and to 1 intervention - of which mHealth adherence app is the first listed.
NCT04976933 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04976933 about?
NCT04976933 is a clinical study titled "Post-HSCT Medication Adherence mHealth App". Through a mixed methods, quasi-experimental design, the study will first focus on developing a mobile health (mHealth) adherence application and evaluating usability and acceptability of the app among caregivers of children in the acute phase post-HSCT. The purpose of this project is to explore the ...
What is the current status of trial NCT04976933?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2021-09-15. Estimated completion is 2023-01-31.
What conditions does trial NCT04976933 study?
This clinical trial studies the following conditions: Stem Cell Transplantation.
What interventions are being tested in trial NCT04976933?
The interventions under investigation include: mHealth adherence app (BEHAVIORAL).
Who is sponsoring clinical trial NCT04976933?
This trial is sponsored by Micah Skeens, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04976933 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation
ACTIVE NOT RECRUITING · NA
-
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
ACTIVE NOT RECRUITING · Phase 2
-
Feasibility Neurocognitive Outcome After Transplant
ACTIVE NOT RECRUITING · NA
-
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
COMPLETED
-
Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
COMPLETED · Early Phase 1
-
The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.